“Our committee of independent experts ensures cost effective treatment options are available for your employees.” — Matt Hosford, vice president and chief pharmacy officer at Wellmark Blue Cross and Blue Shield.
Last year was an exceptional time for new FDA drug and treatment approvals — the highest in more than two decades — making the drug pipeline more robust than ever.
While this is new and promising news for those seeking options to treat their rare and complex diseases and conditions, it caused concern for employers who would ultimately pay the bill.
Luckily, there’s a solution: Wellmark’s pharmacy management program.
As the specialty drug pipeline continues to diversify and grow, you can rely on our Pharmacy and Therapeutics (P&T) committee of experts who are continually monitoring the pipeline and managing our formulary while keeping safety, value and performance top-of-mind. In addition, CVS Health® has the tools and resources to stay ahead by actively monitoring the specialty pipeline for your business to help ensure effective cost management for your bottom line, and your employees to receive the most current standard of care.
Learn about how we are staying ahead in managing the skyrocketing prices External Site Opens PDF of the specialty pipeline drugs inside CVS Health’s Insights Briefing.